CADI™ models selected publications:​

​

• 2023: Frontiers in Neuroscience: H2020-GEMMA: Autism (ASD): “RNA epitranscriptomics dysregulation: A major determinant for significantly increased risk of ASD pathogenesis”. How sudden changes in environmental conditions in utero, such as those conferred by maternal inflammation/immune activation, influence RNA epitranscriptomic mechanisms, with the combination of these processes altering fetal brain development leading to ASD phenotypes. (PDF document).
   

• 2022: Frontiers in Neuroscience:  H2020-GEMMA Publication of the world's first integrative neurodevelopmental model describing the mechanisms and dynamics of ASD pathogenesis in utero and post-partum: "Autism Spectrum Disorders pathogenesis: Toward a comprehensive model based on neuroanatomic and neurodevelopment considerations". (PDF Document). 
   

• 2021: Nutrients: H2020-GEMMA: This Publication belongs to the Special Issue Microbiome, Probiotics and Autism. A novel mechanistic hypothesis on the interaction between the microbiome and the host in ASD affected individuals "Autonomic Nervous System Neuroanatomical Alterations Could Provoke and Maintain Gastrointestinal Dysbiosis in Autism Spectrum Disorder (ASD): A Novel Microbiome–Host Interaction Mechanistic Hypothesis". (PDF document).
   

• 2021, Journal of Nutritional Science: Maternal malnutrition and anaemia in India: dysregulations leading to the ‘thin-fat’ phenotype in newborns, Sanjeev Galand, ISEER Shiv University, François Iris BMSystems, Prachi Pandit Arbuza Regenerate
   

• 2018. Current Opinion in Pharmacology: How scientific literature analysis yields innovative therapeutic hypothesis through integrative iteration.

​

• 2014. CNS Psychiatry: American Journal of Psychiatry and Neuroscience. Second publications with Max Planck  Institute of Psychiatry in Munich: Differential proteomics analyses reveal anxiety-associated molecular and cellular mechanisms in cingulate cortex. The first output of the DECIUS CNS research program. 

​

• 2012. CNS Neurodegenerative & Psychiatry: PharmacoPsychiatry publishes the first review describing a productive vision of Systems Medicine that will change R&D organization and interactions between clinicians & researchers & reveals how the world's first explanation of the mechanisms of the Creutzfeldt-Jakob disease led to the discovery of a  new therapeutic strategies for psychiatric disorders! Clearly, the brain cannot be reduced to its neurons only! 

​

• 2011. CNS Psychiatry; Pharmaco Psychiatry publication: Fith publication with The max Planck Institute of Psychiatry in Munich: Proteome-Based Pathway Modelling of Psychiatric Disorders that describes a new analytical paradigm to definitively move research from plethoric statistical biomarkers.

​

• 2010. Infectious Diseases; Biosecurity and Bioterrorism - Biodefense Strategy, Practice, and Science. Fourth publication with Pherecydes-Pharma: Genetically Engineered Virulent Phage Banks in the Detection and Control of Emergent Pathogenic Bacteria.

​

• 2009. Tissue Differentiation; Medicine & Sciences (French): Third CADI model validated. Mullerian regression explanation. Modelisation integrative predictive et biologie experimentale. Un processus synergique remarquablement efficace au service de la recherche medicale.

​

• 2005. Cancer; Journal of molecular Endocrinology: Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and Tamoxifen in MCF7 breast cancer cells. Publication in collaboration with the INSERM unit 553. 

​

• 2003. Cancer; Nucleic Acids Research: Integrated transcriptome analysis of the cellular mechanisms associated with Ha-ras-dependent malignant transformation of the human breast epithelial MCF7 cell line Publication in collaboration with the INSERM unit 553. World first. First in-silico model of a complex human disease validated in-vitro and published.